Avaliação do risco de viés de ensaios controlados randomizados de odontologia indexados na base de dados Lilacs (Literatura Latino-Americana e do Caribe em Ciências da Saúde) by Ferreira, Christiane Alves et al.
Sao Paulo Med J. 2011;129(2):85-93 85
O
rig
in
al
 a
rti
cle
Assessing the risk of bias in randomized controlled trials in 
the field of dentistry indexed in the Lilacs (Literatura Latino-
Americana e do Caribe em Ciências da Saúde) database
Avaliação do risco de viés de ensaios controlados randomizados de odontologia indexados na base de dados 
Lilacs (Literatura Latino-Americana e do Caribe em Ciências da Saúde) 
Christiane Alves FerreiraI, Carlos Alfredo Salles LoureiroII, Humberto SaconatoIII, Álvaro Nagib AtallahIV
Universidade Federal de São Paulo — Escola Paulista de Medicina (Unifesp-EPM), São Paulo, Brazil
IMSc. Doctoral student in the field of health sciences at Universidade Federal de São Paulo — Escola Paulista de Medicina (Unifesp-EPM), São Paulo, Brazil.
IISpecialist and doctoral student in the field of health sciences at Universidade Federal de São Paulo — Escola Paulista de Medicina (Unifesp-EPM), São Paulo, Brazil.
IIIMD, PhD. Adjunct Professor at Universidade Federal do Rio Grande Norte (UFRN), Natal, Rio Grande do Norte, Brazil.
IVMD, PhD. Titular Professor and Director of the Brazilian Cochrane Center, Universidade Federal de São Paulo — Escola Paulista de Medicina (Unifesp-EPM), São Paulo, Brazil.
ABSTRACT
CONTEXT AND OBJECTIVE: Well-conducted randomized controlled trials (RCTs) represent the highest level of evidence when the research question 
relates to the effect of therapeutic or preventive interventions. However, the degree of control over bias between RCTs presents great variability between 
studies. For this reason, with the increasing interest in and production of systematic reviews and meta-analyses, it has been necessary to develop 
methodology supported by empirical evidence, so as to encourage and enhance the production of valid RCTs with low risk of bias. The aim here was 
to conduct a methodological analysis within the field of dentistry, regarding the risk of bias in open-access RCTs available in the Lilacs (Literatura 
Latino-Americana e do Caribe em Ciências da Saúde) database.
DESIGN AND SETTING: This was a methodology study conducted at Universidade Federal de São Paulo (Unifesp) that assessed the risk of bias in 
RCTs, using the following dimensions: allocation sequence generation, allocation concealment, blinding, and data on incomplete outcomes. 
RESULTS: Out of the 4,503 articles classified, only 10 studies (0.22%) were considered to be true RCTs and, of these, only a single study was classified 
as presenting low risk of bias. The items that the authors of these RCTs most frequently controlled for were blinding and data on incomplete outcomes. 
CONCLUSION: The effective presence of bias seriously weakened the reliability of the results from the dental studies evaluated, such that they would 
be of little use for clinicians and administrators as support for decision-making processes. 
RESUMO
CONTEXTO E OBJETIVO: Ensaios controlados randomizados (ECRs) bem conduzidos representam o mais alto nível de evidência quando a pergunta 
de pesquisa é sobre o efeito de intervenções terapêuticas ou preventivas. No entanto, o grau de controle de viés entre os ECRs apresenta grande 
variabilidade entre estudos. Por esta razão, com o aumento do interesse e produção das revisões sistemáticas e metanálises, foi necessário 
desenvolver metodologia suportada por evidência empírica, para incentivar e valorizar a produção de ECRs válidos e com baixo risco de viés. 
O objetivo deste trabalho foi realizar uma análise metodológica da área de odontologia quanto ao risco de viés de ECRs de acesso aberto, 
disponibilizados no banco de dados do Lilacs (Literatura Latino-Americana e do Caribe em Ciências da Saúde). 
TIPO DE ESTUDO E LOCAL: Trata-se de um estudo sobre metodologia conduzido na Universidade Federal de São Paulo (Unifesp) que avaliou o risco 
de viés dos ECRs, utilizando as seguintes dimensões: geração da sequência de alocação, sigilo da alocação, cegamento e dados sobre desfechos 
incompletos.
RESULTADOS: Dos 4.503 artigos classificados somente 10 (0,22%) estudos foram considerados verdadeiros ECR e, destes, somente um estudo foi 
classificado como sendo de baixo risco de viés. Os itens mais frequentemente controlados pelos autores dos ECR foram cegamento e dados sobre 
desfechos incompletos. 
CONCLUSÃO: A presença efetiva de viés enfraqueceu seriamente a confiança nos resultados dos estudos de odontologia avaliados, sendo pouco 
úteis para clínicos e gestores como suporte a processos de decisão.
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INTRODUCTION 
The history of the efforts to create unbiased comparison groups for 
preventive or therapeutic interventions goes back more than three cen-
turies.1 Randomized clinical trials (RCTs), in the form in which they 
are known today, were introduced within medical science by Bradford 
Hill at the end of the 1940s. According to the Glossary of Terms in 
the Cochrane Collaboration, RCTs are a type of prospective study in 
which two or more interventions introduced by the investigator are 
compared. Of these, one is a control group (in which non-interven-
tion, placebo or a standard intervention is used). RCTs use participant 
allocation sequences that are random.2
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Well-conducted RCTs represent the individual highest level of evi-
dence when the research question relates to the effect of therapeutic 
or preventive interventions. However, the degree of control over bias 
between RCTs presents great variability between studies. For this rea-
son, with the increasing interest in and production of systematic reviews 
and meta-analyses, it has been necessary to develop validated tools that 
might help to evaluate the risk of bias in RCTs. The aim of such tools 
is to ensure that the clinical question is answered correctly, i.e. with an 
effect size that is as close as possible to the truth. RCTs with a high risk 
of bias may overestimate or underestimate the magnitude of interven-
tions, and the misleading nature of such results may compromise clini-
cal decision-making.3
OBJECTIVE 
The objective of the present study was to conduct a methodologi-
cal analysis within the field of dentistry, regarding the risk of bias among 
open-access RCTs that are available in the Lilacs (Literatura Latino-Amer-
icana e do Caribe em Ciências da Saúde) database, which is a regional da-
tabase covering literature from Latin America and the Caribbean.
METHODS
The studies were retrieved through a hand search in open-access 
dental journals that are indexed in the Lilacs database and available on 
the internet (www.bireme.br). For this, a time period of six years was es-
tablished (2002, 2003, 2004, 2005, 2006 and 2007). 
An initial search in Lilacs identified 93 journals within the fields of 
dentistry or orthodontics. Of these, 74 were current journals, 40 were 
open-access, seven were available on subscription and the remainder was 
unavailable in Lilacs. These 40 journals were selected and a hand search 
was conducted in these, in order to classify the study designs and iden-
tify the RCTs (Figure 1). Studies were eligible for inclusion regardless of 
the participants’ ages, clinical conditions, contexts, genders or ethnicity. 
Any type of intervention carried out on human beings was eligible. Any 
type of outcome was eligible, and RCTs were not excluded as a function 
of the relevance or irrelevance of the outcomes. The main criterion for a 
more detailed assessment was the presence or indication of randomiza-
tion or random allocation as terms in the title or abstract of study.
Empirical evidence supports at least six dimensions as potential 
sources of risk of bias in RCTs: randomized allocation sequence,4 al-
location sequence concealment,4 blinding,5 evaluation of incomplete 
outcome data,6 selective outcome reporting7 and other biases. Adequate 
procedures for these items are important for ensuring internal validity 
for RCTs.8 The Cochrane Handbook for Systematic Reviews of Inter-
ventions recommends a tool that independently assesses these dimen-
sions of RCTs, taking them as isolated domains without attributing 
weights or different ranks to them. For each of these dimensions, three 
response options were offered: yes (low risk of bias; score 2), when this 
dimension was correctly implemented and reported; no (high risk of 
bias; score 0), when this dimension was not implemented or not report-
ed, or if an invalid method was reported; or unclear risk (unclear risk of 
bias for one or more domains; score 1), when the implementation meth-
od or the report left doubts.2
The classification (Higgins and Green: 2 a classification used to sum-
marize the risk of bias according to domains in each study and between 
studies) made it possible to rank each of the studies individually and 
to rate the validity of publications for a set of studies, as in the scheme 
below:
•	 Low	risk	of	bias:	unlikely	to	be	enough	biased	to	seriously	change	
the results; within studies: low risk of bias for all domains; set of 
studies: most of the information comes from studies with a low risk 
of bias;
•	 Unclear	risk	of	bias:	plausible	bias	that	raises	some	doubt	about	the	
results; within studies: unclear risk of bias for one or more domains; 
set of studies: most of the information comes from studies with a 
low risk of bias;
•	 High	risk	of	bias:	plausible	bias	that	seriously	weakens	the	reliability	
of the results; within studies: high risk of bias for one or more key 
domains; set of studies: the proportion of the information coming 
from studies with a high risk of bias is enough to affect the interpre-
tation of the results. 
To assess the risk of bias in studies considered to be potential RCTs, 
two independent reviewers (CAF and CAL) rated each study in order to 
ensure that these trials could be reproduced.9 Disagreements were dis-
cussed until reaching a consensus. The inter-rater reliability between the 
reviewers was measured using Cohen’s kappa statistics. The reliability 
was considered outstanding: kappa = 0.824. 
The statistical analyses were performed using the Statistical Package 
for the Social Sciences (SPSS) software, version 12.0 for Windows. Multi-
ple logistic meta-regression was used to determine the percentage variance 
in the dependent variable “statistical significance” of the studies caused by 
the dimensions of bias. This was taken to be a yes/no category that could 
be explained by the following independent variables: generation of alloca-
tion, allocation sequence concealment, blinding and incomplete outcome 
data. Only the main outcome of the RCTs was considered, in determin-
ing the significance of the study. The method used consisted of free entry 
of variables and removal of variables that did not fit with the model. The 
significance level used in the tests was 5% (alpha = 0.05), i.e. tests were 
taken to be statistically significant with p values less than 5% (P < 0.05).
This	study	was	submitted	to	the	Research	Ethics	Committee	of	Uni-
versidade	Federal	de	São	Paulo	—	Escola	Paulista	de	Medicina	(Unifesp-
EPM), under the number 1891/06, and was approved.
RESULTS
Table 1 presents the frequencies and percentages of studies classi-
fied in the categories of RCT and other study designs, the frequency and 
percentage of unclassified studies, the absolute frequency, the annual 
percentage and the total number of studies evaluated.
The journals evaluated contributed 4,879 articles. Among these, 
4,581 could be classified regarding the study design, while no classifi-
cation was possible for 298 (6.11%). Among the classified studies, 78 
(1.73%) were initially classified as potential RCTs, while 4,503 were 
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classified as other types of design. Over the study period, the data indi-
cated a trend of growth in the total number of studies and in the num-
ber of RCTs.
Table 2 presents the studies, evaluated according to author, year of 
publication, classification of risk of bias in the dimensions, classification 
of the risk of bias in each study, the statistical significance of the main 
outcome assessed and the frequency of dimensions with a low risk of 
bias in each study.10-87
Among the 78 studies evaluated, 77 (98.72%) were classified as pre-
senting a high risk of bias for all dimensions assessed; 6 (7.69%) for three 
dimensions; nine (11.54%) for two dimensions; and 27 (34.62%) for 
only one dimension. A single study (1.28%)58 was classified as present-
ing low risk of bias for all of the dimensions. In summary, 77 (98.72%) 
of the articles were classified as studies presenting a high risk of bias and 
only one study (1.28%) was classified as presenting a low risk of bias. 
None of the studies was classified as presenting an unclear risk of bias, 
since the combination of one unclear dimension and other dimensions 
with a low risk of bias did not occur.
With regard to statistical significance, 28 studies (35.90%) present-
ed an effect size with a significant difference in favor of the interven-
tion, while there was no significant difference in 40 studies (51.28%) 
and nine studies (11.54%) were not formally assessed, statistically. All 
of the studies that controlled for three or more dimensions presented 
non-significant results.
Figure 2 presents the risk classification graphically, between high, 
unclear and low risk, for the four dimensions evaluated in the 78 open-
access RCTs evaluated.
Among the 78 studies evaluated, the dimension for which the risk 
of bias was most correctly controlled for was blinding, in which 26 stud-
ies (33.33%) presented a low risk of bias. This was followed by control-
ling for incomplete outcome data, in which 23 studies (29.49%) were 
classified as presenting a low risk of bias. Ten studies (12.82%) present-
ed a low risk of bias in relation to the method for generating the alloca-
tion, seven studies (8.97%) in relation to allocation sequence conceal-
ment. Thirty-six studies (46.15%) among the sample of studies evalu-
ated did not control for the risk of bias relating to any of the dimensions 
under examination. 
Table 3 presents the results from the logistic meta-regression for eval-
uating the association between the risk of bias in the domains assessed and 
the statistical significance of the main outcomes of the studies. 
The logistic meta-regression indicated that among the four domains, 
only the allocation sequence generation and the blinding were associat-
ed with the statistical significance of the outcomes. Studies that used 
correct sequences for generating the allocation presented a chance of 
presenting significant results that was 2.20 times greater, but the associ-
ation was not significant (P = 0.07). Studies that used blinding reduced 
the chance of presenting significant results by a factor of 2.28 times.
DISCUSSION
One of the limitations of this study was that it was restricted to evalu-
ating the journals containing open-access studies that are indexed in Li-
Table 1. Frequencies and percentages of studies classified in the categories 
of randomized controlled trial (RCT) and other designs, indexed in the Lilacs 
database, frequency and percentage of unclassified studies, absolute 
frequency, annual percentage and total number of studies evaluated
Variables
Publication year
2002 2003 2004 2005 2006 2007 Total
Total articles 427 606 693 938 1124 1091 4879
% per year 8.80 12.40 14.20 19.20 23.00 22.40 100.00
Unclassified studies 55 64 39 54 52 34 298
Classified studies 372 542 654 884 1072 1057 4581
% unclassified 12.88 10.56 5.63 5.76 4.63 3.12 6.11
RCTs 4 15 12 8 21 18 78
Other designs 368 527 642 876 1051 1039 4503
% RCTs 1.09 2.85 1.87 0.91 2.00 1.73 1.73
Lilacs = Literatura Latino-Americana e do Caribe em Ciências da Saúde.
93 dentistry journals indexed in Lilacs 
74 currently published 19 ceased publications  
47 open access 27 closed access 
7 excluded 
40 evaluated 
Figure 1. Flowchart for journal retrieval.
lacs. These only represent part of the scientific production of a country or 
region. Some articles within the field of dentistry are published in journals 
with restricted access or in medical journals, and there is a growing ten-
dency towards publication in dentistry in international journals that are 
not indexed in Lilacs.88 On the other hand, the present investigation used 
a hand search, which is considered to be the gold standard: it is more sen-
sitive and retrieves between 92% and 100% of the RCTs. Traditional elec-
tronic searches may retrieve 42% of the RCTs, while searches using highly 
sensitive strategies (HSS) that do not exist for Lilacs may retrieve up to 
80% of the RCTs.89 In the present study, the hand search retrieved 4,879 
open-access studies. The quantity of open-access studies within dentistry 
went up from 2.44% in 2002 to 5.18% in 2007, in relation to the total 
number of health studies, independent of the subject. 
The reason for the use of regional databases is the ability to com-
plement the large international databases to adequately answer clinical 
questions and provide contextual evidence to support decision-making 
processes to meet the needs of local or regional populations and help 
solving the global information poverty.90 Clark and Castro91 analyzed 
the Lilacs database and found that in 71% of the cases, a search in 
this database could be useful for the authors of systematic reviews. The 
data from the present study indicated that, if evaluated systematically 
and rigorously, only 78 (1.70%) out of the 4,581 studies were potential 
RCTs and 10 (0.02%) were true RCTs, because only these 10 studies 
used correct allocation sequence generation.
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Authors Year
Sequence 
generation
Allocation sequence 
concealment
Blinding
Incomplete 
outcome data
Risk of 
bias
Significance
Dimensions with low 
risk of bias
Aguiar and Saliba10 2004 No No Yes Yes High Yes 2
Alves et al.11 2003 No No Yes Unclear High No 1
Amaral et al.12 2006 No No No Unclear High Yes 0
Andrade et al.13 2005 No No Yes Unclear High No 1
Bellón Leyva and Calzadilla Mesa14 2007 No No No Unclear High Yes 0
Bermudez-Cuesta et al.15 2004 No No No Unclear High Yes 0
Bortolluzi et al.16 2007 No Yes Yes Yes High No 3
Botelho et al.17 2007 Yes No Yes Yes High No 3
Braga et al.18 2006 No No No Yes High Yes 1
Calvo et al.19 2006 No No Yes Yes High No 2
Camps Mullines et al.20 2007 No No No Unclear High No 0
Cardoso and Buzalaf21 2004 No No No Unclear High No 0
Castillo Castillo et al.22 2006 No No No Yes High Yes 1
Chambrone et al.23 2007 No No Yes Unclear High No 1
Colombo et al.24 2003 Yes No Yes Unclear High Yes 1
Conti et al.25 2005 No No Yes Unclear High Yes 1
Corona Carpio et al.26 2006 No No No No High NA 0
Cortés Vargas et al.27 2002 No No Yes Yes High No 2
Costa et al.28 2007 No Yes Yes Yes High No 3
Cruz Chu and Díaz-Pizán29 2005 No No No Unclear High No 0
Cury et al.30 2003 No No Yes Unclear High No 1
Damante et al.31 2004 No No Yes Unclear High No 1
de Assis et al.32 2006 Yes No Yes Yes High No 3
Dercelli et al.33 2007 No No Yes Unclear High No 1
Dourado et al.34 2005 No No No Unclear High No 0
Elias et al.35 2006 No Unclear No No High No 0
Faraco et al.36 2003 Unclear No Yes Unclear High No 1
Frazao et al.37 2004 No Unclear Yes Yes High No 2
García López et al.38 2003 No No No No High Yes 0
García Arocha et al.39 2004 Yes No Yes Yes High No 3
Gentille and Greghi40 2004 No No No Unclear High No 0
Gispert Abreu et al.41 2004 Unclear No Unclear Yes High Yes 1
Gispert Abreu et al.42 2006 No No Unclear Yes High Yes 1
Gómez et al.43 2003 No No Unclear Yes High No 1
Gonçalves et al.44 2004 Yes No Yes Unclear High Yes 2
Gonzáles Rodríguez et al.45 2007 No No No Unclear High Yes 0
Grisi et al.46 2006 No No Yes No High No 1
Guimarães et al.47 2006 No Yes Yes Yes High No 3
Kogawa et al.48 2005 Yes No Yes Unclear High Yes 2
Laureano Filho et al.49 2003 No No No Unclear High No 0
Lima et al.50 2003 No Yes Yes No High No 2
Llerena et al.51 2006 No No Unclear Unclear High NA 0
Martínez Ramos et al.52 2007 No No No No High NA 0
Medina Vega et al.53 2006 No No No Unclear High No 0
Miura et al.54 2007 No No No Yes High No 1
Mora Loya et al.55 2003 Yes No No Unclear High No 1
Moraes et al.56 2007 No Unclear No Unclear High NA 0
Orellana et al.57 2007 No No Unclear Unclear High No 0
Ozaki et al.58 2006 Yes Yes Yes Yes Low No 4
Pannuti et al.59 2003 No Unclear Unclear Yes High No 1
Pannuti et al.60 2003 No No Unclear Unclear High Yes 0
Peña Ruiz et al.61 2007 No No Unclear Yes High No 1
Pereira et al.62 2007 No No No Unclear High Yes 0
Peruzzo et al.63 2007 Yes Yes No Unclear High Yes 2
Pinheiro et al.64 2004 No No No No High No 0
Proaño de Casalino and Guillen Galarza65 2005 Yes No No Unclear High Yes 1
Querido et al.66 2004 No No Unclear Unclear High NA 0
do Rego et al.67 2003 No No No Unclear High Yes 0
Rivera et al.68 2006 No No Yes Unclear High NA 1
Rojano Santillán et al.69 2004 No No No Unclear High No 0
Rojas de Morales et al.70 2002 Unclear No Unclear No High Yes 0
Roscher et al.71 2004 No No No Yes High No 1
Salazar de Plaza et al.72 2002 No No No No High NA 0
Salgado et al.73 2006 No Yes Unclear Yes High Yes 2
Samra Quintero et al.74 2006 No No No Unclear High No 0
Shintome et al.75 2007 No No No Unclear High Yes 0
Silva et al.76 2006 No No No Unclear High Yes 0
Soares et al.77 2006 No No No Unclear High NA 0
Tavares et al.78 2007 No No No No High NA 0
Torres et al.79 2007 No No No Yes High No 1
Ubeda et al.80 2005 No No Unclear Unclear High Yes 1
Valle García et al.81 2002 No No No Unclear High Yes 0
Vasconcelos et al.82 2005 No No No Unclear High No 0
Vasconcelos et al.83 2006 No No No Unclear High Yes 0
Vergani et al.84 2004 No No Yes No High No 1
Vieira et al.85 2006 No No Unclear Yes High Yes 1
Virga et al.86 2006 No No Unclear No High Yes 0
Zanata et al.87 2003 Unclear No No No High Yes 0
RCT Low risk of bias 10 7 26 23 1  66
Table 2. Authors, year of publication, methodological characteristics and classification of risk of bias in each potential RCT, statistical significance of the 
main outcome assessed and the frequency of dimensions with a low risk of bias
NA = not assessed; RCT = randomized controlled trial.
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Table 3. Logistic meta-regression, risk of bias in the domains assessed and the statistical significance of the main outcomes of the studies
Variable B Standard error Wald’s test df Sig Exp(B)
95% CI
Lower boundary Upper boundary
Sequence generation 0.706 0.392 3.238 1 0.072 2.025 0.939 4.368
Blinding -0.826 0.327 6.400 1 0.011 0.438 0.231 0.830
Constant 0.157 0.371 0.179 1 0.673 1.170
Variables used in the first stage: sequence generation, allocation concealment, blinding and incomplete outcome data.
Dependent variable: significant difference.
CI = confidence interval; df = degrees of freedom; Sig = significance; Exp(B) = beta exponent.
Figure 2. Risk of bias shown graphically, between high, unclear and low risk, for the four dimensions evaluated in the 78 open-access randomized 
controlled trials (RCTs).
Sequence generation                                            
Allocation concealment                                            
Blinding                                            
Incomplete outcome data                                            
Percentage (%)  0  5 10  15  20  25  30 35  40  45  50  55  60 65 70  75  80  85  90  95  100  
Legend: grey = low risk of bias; white = unclear risk of bias; black = high risk of bias
The main role of correct random sequence generation for the alloca-
tion is to ensure that the groups are balanced, in relation to both known 
and unknown factors, thus equalizing the initial prognosis before intro-
ducing the experimental intervention. For this dimension, among the 
78 RCTs evaluated, 64 (82.05%) did not report on it or used an incor-
rect method, four studies (5.13%) were classified as unclear and only 10 
studies (12.82%) used a method that was truly randomized for generat-
ing the allocation sequence for the groups. Among these ten random-
ized studies, five of them used simple or unrestricted randomization, 
among which four studies24,39,44,58 used random number tables and one 
study48 used a computer-generated random sequence. The other five au-
thors used restricted sequences for generating the allocation: Botelho 
et al.17 used randomization in blocks, from a computer-generated list; 
Proano de Casalino and Guillen Galarza,65 de Assis et al.32 and Peruzzo 
et al.63 tossed a coin; and Mora Loya et al.55 used a random number ta-
ble, but in a restricted manner. Many authors reported that their study 
was randomized but did not report the method used and many men-
tioned randomization only in the title or abstract but did not report it 
in the text of the article. Other studies reported the randomization as 
synonymous with allocation to groups through the judgment of an ex-
perienced researcher.
Since 1995, there has been good empirical evidence regarding the 
effects from non-randomized allocation sequences. Schulz et al.5 found 
that, on average, studies with inadequate allocation sequences exagger-
ated the odds ratios by 41% and by 30% for unclearly concealed trials 
(after adjustment for other aspects of quality), in comparison with the 
studies that used adequate sequence allocation. The results suggested 
that if the allocation is not randomized, even in studies with correct al-
location sequence concealment, it is possible for the investigators and 
patients to decipher the allocation of the participants to some degree. 
Recently Kunz et al.92 confirmed empirically that not using randomized 
generation of sequence allocation, or using it inadequately, could result 
in overestimates of the interventions. However, this bias may occur in 
either direction: in favor of or against the intervention. In the present 
review, correct use of sequence generation for the allocation doubled 
the chance that the study would furnish significant results, although 
the meta-regression did not produce a significant result. This was prob-
ably because of type II error due to the small sample of articles and the 
type of outcome used (statistical significance), which requires a major 
difference in effect size for it to be greater than what might be expected 
by chance.
The first meta-epidemiological study to provide empirical evidence 
regarding the effect from allocation concealment was published in 
1995.4 This evidence was confirmed subsequently by other studies.93,94 
These studies together involved evaluations on 1,615 primary studies. 
More recently, Wood et al.95 evaluated 102 meta-analyses and 804 stud-
ies and concluded that lack of allocation sequence concealment pro-
duced a mean increase in the estimates of 17%. This deviation did not 
occur or was smaller in studies that measured objective outcomes (9%) 
and was greater in subjective studies (31%). The importance of alloca-
tion sequence concealment is that its absence or incorrect use may re-
sult in bias in selecting participants based on prognostic factors, even in 
the presence of a correct method for generating the allocation. For ex-
ample, when the result from the random draw is known, patients allo-
cated to a given type of intervention may be considered inadequate and 
be eliminated from the study. Randomization associated with allocation 
sequence concealment may avoid selection bias, but when used alone, it 
may be insufficient to avoid this type of bias. In the present evaluation, 
67 studies (85.90%) presented high risk of bias, four (5.13%) studies 
were unclear and only seven studies (8.97%) reported a correct method 
for the concealment of allocation. Among the latter, only two studies58,63 
used complete control over selection bias, through concomitantly us-
ing randomization and allocation sequence concealment. Lima et al.,50 
Ozaki et al.,58 Salgado et al.,73 Bortolluzy et al.,16 Costa et al.,28 Moraes 
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et al.56 and Peruzzo et al.63 used central randomization by third parties, 
or sequentially numbered envelopes or packages containing medications 
or the test and control substances. Guimarães et al.47 used opaque sealed 
envelopes. Allocation sequence concealment was the least frequently ob-
served dimension among the articles evaluated, and was the most fre-
quent source of confusion with blinding. 
Lack of blinding may lead to performance bias, thus signifying a sys-
tematic difference between the groups, with regard to the care received, 
because of intentional exposure to different co-interventions other than 
the experimental intervention. It may also induce detection bias, which 
results in systematic differences between groups regarding the way in 
which outcomes are measured or reported.2 While there is empirical 
evidence that generation and allocation sequence concealment are more 
homogenous regarding modification of the effect size of interventions, 
double blinding produces bias of smaller magnitude and the deviations 
are more heterogenous. Colditz et al.96 evaluated 113 RCTs and found 
that if correct blinding was used, the effects obtained from the interven-
tions were more modest. Empirical studies have indicated that incorrect 
blinding increases the size of the effect from interventions by an aver-
age of 9%.97 The impact from lack of blinding varies according to the 
type of outcome. Objective and very marked outcomes such as mortal-
ity are less influenced by absence of blinding and sometimes may not 
need this type of control. Subjective studies are much more susceptible 
to this type of bias.95 In the present study, blinding was the bias control 
dimension most frequently seen among the studies evaluated. Out of 
the 78 studies, 26 (33.33%) used a correct method of blinding, even if 
not all of them were double blind. One study46 reported a triple blind 
method, while nine studies reported a double-blind method: de Assis 
et al.,32 Bortolluzy et al.,16 Botelho et al.,17 Calvo et al.,19 Faraco et al.,36 
Guimarães et al.,47 Kogawa et al.,48 Rivera et al.68 and Vieira et al.86 Fif-
teen studies reported single blinding of the healthcare providers or out-
come assessors.10,23,25,27,28,30,31,33,37,39,44,46,50,58 In another 14 studies, the au-
thors reported blinding but did not describe the method, or blinding 
was impossible. The studies by Gispert Abreu et al.41 and Gispert Abreu 
et al.42 were examples of the impossibility of blinding, because there was 
no report of any alternative treatment or placebo for the controls.
In the present study, it was found that 23 studies (29.49%) were 
classified as presenting low risk of bias for the dimension of incomplete 
outcome data, while 55 studies (70.51%) presented an unclear or high 
risk of bias. Some studies stated that the number of participants at the 
end of the study was identical to the number that underwent the initial 
examination. For some of these studies, this coincidence did not seem 
plausible, which suggests that participants who started the study but did 
not complete it were simply disregarded, and that only the number of 
participants who completed the study was considered for the analysis. 
In such cases, the loss of participants was erroneously reported as zero. 
Among the studies that evaluated or reported missing data, none of 
them used intention-to-treat analysis. 
The empirical evidence for evaluating the effect of incomplete out-
come data on the magnitude of the effects from interventions was as-
sessed by Tierney et al.98 They evaluated 14 meta-analyses on individual 
patients’ data and found that incomplete outcome data had a real effect 
on the outcomes and that the bias was greater in the treatment group 
than in the control group. In 2009, Nüesch et al.99 evaluated 14 meta-
analyses with subjective outcomes that included 167 trials and 41,170 
participants. The results indicated that trials with incomplete outcome 
data tended to present results that were between 25% and 50% more 
favorable to the intervention.
Taking into account the set of 4,581 studies, only one study (0.22%) 
was classified as presenting low risk of bias for the four dimensions as-
sessed and 77 potential RCTs (98.72%) were classified as presenting 
high risk of bias.
The level of bias control in the set of studies evaluated in Lilacs in-
dicates that this is a body of evidence with less validity than that found 
in other databases such as Medline. When evaluating 3,631 studies on 
dental prostheses from journals indexed in Medline, Dumbrigue et al.100 
found that 1.71% were RCTs and 16% had a low risk of bias. Monte-
negro et al.101 found that in periodontics, RCTs were frequently of poor 
quality. The sequence generation could only be assessed in 17% of the 
RCTs and the allocation was only concealed in 7% of the RCTs evalu-
ated. Blinding was implemented slightly more frequently, in 55% of 
the RCTs. The dimension of incomplete outcome data could not be as-
sessed in 44% of the RCTs. Sjögren and Halling et al.102 evaluated 200 
medical and dental RCTs and found that, in relation to generation of 
randomization, although the RCTs mentioned the term “randomiza-
tion”, only one third of them presented a true method for generating 
randomization. Inadequate methods were reported in 6% of the RCTs 
and two thirds of the RCTs did not present any randomization method. 
Regarding allocation sequence concealment, these same authors found 
that only 13% of the dental RCTs and 9% of the medical RCTs report-
ed adequate methods. With regard to blinding, they found that 28% 
of the dental RCTs and 4% of the medical RCTs implemented double 
blinding, but that the method was only adequate in 18% of the den-
tal RCTs and 2% of the medical RCTs. Regarding incomplete outcome 
data, 35% of the dental RCTs and 44% of the medical RCTs reported 
this item, thus suggesting that the risk of bias due to incomplete data 
was low. In an assessment on RCTs relating to implant dentistry pub-
lished over 10-year period (1991 to 2000), Dumbrigue et al.100 found 43 
possible RCTs. The randomization method was explicit in 51% of the 
RCTs, but only 12% incorporated blinding in assessing the outcome. 
Looking at overall quality scores, only 2% of the RCTs adequately re-
ported on control of bias in the three areas examined, while 56% were 
deficient in one area and 42% were deficient in two areas. Reporting 
of randomization procedures and blinding of outcomes for most of the 
implant RCTs was inadequate. Subject retention and documentation of 
subject withdrawals were adequately reported. Although the number of 
RCT’s in dentistry with low risk of bias is not encouraging, the Lilacs 
database presents a worse situation than do other databases.
The distribution of the RCTs according to the importance that their 
authors gave to the issue of bias control, as reflected in the different de-
grees to which this was implemented, did not correspond to the poten-
tial for changing the effect size. This suggests that the same problem 
that exists in the gap between the best available clinical evidence and 
its adoption in practice103 is also an evident gap between the empirical 
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evidence in meta-epidemiological studies and the choice of dimensions 
used in the studies. Guidelines and better dissemination of evidence re-
lating to methodology are needed in order to reduce this gap.
The results from the present study indicated that the proportion 
of information coming from studies with a high risk of bias that were 
published in open access journals indexed in Lilacs was sufficient to se-
riously affect the interpretation of the results. The effective presence of 
bias seriously weakened the reliability of the results from the studies 
evaluated, thus indicating that there is practically no trustworthy evi-
dence that clinicians and administrators can use as support for decision-
making processes in the field of dentistry. In other words, the internal 
validity of most the RCTs evaluated was very poor. Future studies will 
need to investigate whether this is a question relating to the database 
examined (Lilacs) or to accessibility, given that all of the RCTs evalu-
ated were available with open-access; or whether there is a situation of 
extreme insufficiency of quantity of and control for the risk of bias in 
RCTs within the field of clinical dental research in Latin America and 
the Caribbean region.
CONCLUSION
Out of the 4,879 articles classified, only 10 studies (0.22%) were 
considered to be true RCTs and, of these, only a single study was classi-
fied as presenting low risk of bias.
All of the studies that controlled for three or more dimensions of 
potential sources of risk of bias presented non-significant results. The 
item that the authors of these RCTs most frequently controlled for was 
blinding. There is an evident gap between the empirical evidence pro-
duced by meta-epidemiological studies and the importance and fre-
quency of use of bias control in studies on dentistry.
The effective presence of bias seriously weakened the reliability of 
the results from the dental open-access studies evaluated in the Lilacs 
database, such that they were of little use in dentistry for elaborating 
guidelines or systematic reviews as support for decision-making pro-
cesses.
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